We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current B1GN34 market cap is 0. The company's latest EPS is USD -0.6486 and P/E is -23.34.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 781.31M | 634.41M | 751.65M | 929.17M | 1B |
| Operating Income | -133.97M | -383.8M | -261.35M | -107.16M | -120.27M |
| Net Income | 215.41M | -367.55M | -251.15M | -120.41M | -121.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 428.21M | 308.87M | 1.18B | 1.42B | 2.46B |
| Operating Income | -959.89M | -1.66B | -1.44B | -1.79B | -1.21B |
| Net Income | -948.63M | -1.6B | -1.41B | -2B | -881.71M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.52B | 5.81B | 5.67B | 5.71B | 5.83B |
| Total Liabilities | 1.76B | 2.27B | 2.31B | 2.35B | 2.39B |
| Total Equity | 3.76B | 3.54B | 3.36B | 3.37B | 3.44B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.61B | 5.6B | 8.65B | 6.38B | 5.81B |
| Total Liabilities | 633.93M | 1.73B | 2.4B | 2B | 2.27B |
| Total Equity | 978.36M | 3.87B | 6.24B | 4.38B | 3.54B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -935.82M | -1.16B | -308.57M | -404.16M | -215.79M |
| Investing | 122.59M | 60M | -209.83M | -320.86M | -454.75M |
| Financing | 69.43M | 416.48M | 162.29M | 185.31M | 197.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -750.27M | -1.28B | -1.3B | -1.5B | -1.16B |
| Investing | 554.16M | -3.17B | 640.66M | 1.08B | 60M |
| Financing | 85.68M | 5.2B | 3.64B | -18.97M | 416.48M |
| Market Cap | 0 |
| Price to Earnings Ratio | -23.34 |
| Price to Sales Ratio | 8.37 |
| Price to Cash Ratio | 6.49 |
| Price to Book Ratio | 5.82 |
| Dividend Yield | - |
| Shares Outstanding | 1.36B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 54.55 |
| 52 Week Low | 27.12 |
| Spread (Intraday) | 0 (0%) |
| Company Name | BeiGene Ltd |
| Address |
94 solaris avenue grand cayman KY1 1104 |
| Website | https://www.beigene.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
